Utility of Nine-Color, 11-Parameter Flow Cytometry for Detection of Plasma Cell Neoplasms
Open Access
- 1 September 2014
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 142 (3), 398-410
- https://doi.org/10.1309/ajcpo5gqpxf8qcec
Abstract
Multiparameter flow cytometry (MFC) is a widely available laboratory platform for the evaluation of plasma cell (PC) neoplasms. We assess the performance of a nine-color MFC assay that uses stain-lyse-fix processing of bone marrow aspirates, minimal wash steps, and high acquisition rates with analysis of up to 1.8 × 106 cells. MFC results were compared with microscopic examinations, immunohistochemical studies, and serum/urine M-protein measurements from patients with documented or suspected PC neoplasms. Sensitivity exceeded that of microscopic examinations, with or without immunohistochemistry. In patients with PC myeloma, clonal PC detection by MFC fell in concert with M-protein levels. However, in a subset of patients, MFC detected clonal PCs after serum/urine studies turned negative. The nine-color analytic cocktail eliminates duplication of PC gating reagents required for evaluation of the same epitopes using a five- or six-color approach. Fewer analytic cocktails result in lower instrument acquisition times per case, a significant factor for the large data sets required for optimal residual disease assessment. Finally, concurrent analysis of nine epitopes and two light scatter parameters aids detection of residual disease, particularly when it is mixed with polyclonal PCs.Keywords
This publication has 28 references indexed in Scilit:
- Immunophenotypic heterogeneity of normal plasma cells: comparison with minimal residual plasma cell myelomaJournal of Clinical Pathology, 2012
- A GEIL flow cytometry consensus proposal for quantification of plasma cells: Application to differential diagnosis between MGUS and myelomaCytometry Part B: Clinical Cytometry, 2010
- Single Tube, Six-Color Flow Cytometric Analysis Is a Sensitive and Cost-Effective Technique for Assaying Clonal Plasma CellsAmerican Journal of Clinical Pathology, 2010
- Utility of flow cytometry immunophenotyping in multiple myeloma and other clonal plasma cell‐related disordersCytometry Part B: Clinical Cytometry, 2010
- Flow Cytometric Immunophenotyping and Minimal Residual Disease Analysis in Multiple MyelomaAmerican Journal of Clinical Pathology, 2009
- Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patientsHaematologica, 2009
- Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantationBlood, 2008
- Instability of Immunophenotype in Plasma Cell MyelomaAmerican Journal of Clinical Pathology, 2008
- International uniform response criteria for multiple myelomaLeukemia, 2006
- Serum Free Light Chain (FLC) Measurement Can Aid Capillary Zone Electrophoresis in Detecting Subtle FLC-Producing M ProteinsAmerican Journal of Clinical Pathology, 2005